Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases

Internal Medicine

Volumn 50, Issue 23, 2011, Pages 2889-2892

  Doishita, Satoshi ^a   Inokuma, Shigeko ^a   Asashima, Hiromitsu ^a   Nakachi, Shinichiro ^a   Matsuo, Yoshimi ^a   Rokutanda, Ryo ^a   Kobayashi, Shoko ^a   Hagiwara, Kiyofumi ^a   Satoh, Takeo ^a   Akiyama, Osamu ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Connective tissue diseases; Cut off level; Interstitial pneumonitis; KL 6

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN; KREBS VON DEN LUNGEN 6 PROTEIN; METHYLPREDNISOLONE; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; KREBS VON DEN LUNGEN 6 BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCIN-1;

EID: 82855166027     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5866     Document Type: Article

References (12)

1. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96: 68-73, 1989.
2. http://www.sanko-junyaku.co.jp/product/diagnose/catalog/meneki/lp-kl6.html. (accessed 1 April 2011).
3. Sun AP, Ohtsuki Y, Fujita J, Ishida T, Yoshinouchi T, Kohno N. KL-6, a human MUC1 mucin, is expressed early in premature lung. Respir Med 97: 964-969, 2003.
4. Ohtsuki Y, Nakanishi N, Fujita J, et al. Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias. Med Mol Morphol 40: 163-167, 2007.
5. Yanaba K, Hasegawa M, Hamaguchi Y, Fujimoto M, Takehara K, Sato S. Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis. Clin Exp Rheumatol 21: 429-436, 2003.
6. Oyama T, Kohno N, Yokoyama A, et al. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin. Lung 175: 379-385, 1997.
7. Kubo M, Ihn H, Yamane K, et al. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology (Oxford) 39: 632-636, 2000.
8. Iwata Y, Wada T, Furuichi K, et al. Serum levels of KL-6 reflect disease activity of interstitial pneumonia associated with ANCA-related vasculitis. Intern Med 40: 1093-1097, 2001.
9. Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med 260: 429-434, 2006.
10. Nakajima H, Harigai M, Hara M, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 27: 1164-1170, 2000.
11. Okada M, Suzuki K, Matsumoto M, et al. Intermittent intravenous cyclophosphamide pulse therapy for the treatment of active interstitial lung disease associated with collagen vascular diseases. Mod Rheumatol 17: 131-136, 2007.
12. Kobayashi J, Itoh Y, Kitamura S, Kawai T. Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia. Rinsho Byori 44: 653-658, 1996 (in Japanese).